US4164559A
(en)
|
1977-09-21 |
1979-08-14 |
Cornell Research Foundation, Inc. |
Collagen drug delivery device
|
ES8401486A1
(es)
|
1981-11-10 |
1983-12-01 |
Wellcome Found |
Un procedimiento para la preparacion de nuevos derivados de imidazo (4,5-c)piridina.
|
US4474752A
(en)
|
1983-05-16 |
1984-10-02 |
Merck & Co., Inc. |
Drug delivery system utilizing thermosetting gels
|
US4783443A
(en)
|
1986-03-03 |
1988-11-08 |
The University Of Chicago |
Amino acyl cephalosporin derivatives
|
EP0410509A1
(en)
|
1989-07-25 |
1991-01-30 |
Duphar International Research B.V |
New substituted 1H-indazole-3-carboxamides
|
GB9414139D0
(en)
|
1994-07-13 |
1994-08-31 |
Smithkline Beecham Plc |
Novel compounds
|
US6440102B1
(en)
|
1998-07-23 |
2002-08-27 |
Durect Corporation |
Fluid transfer and diagnostic system for treating the inner ear
|
DE19853299C2
(de)
|
1998-11-19 |
2003-04-03 |
Thomas Lenarz |
Katheter zur Applikation von Medikamenten in Flüssigkeitsräumen des menschlichen Innenohrs
|
US6120484A
(en)
|
1999-02-17 |
2000-09-19 |
Silverstein; Herbert |
Otological implant for delivery of medicament and method of using same
|
NZ516292A
(en)
|
1999-05-21 |
2004-01-30 |
Bristol Myers Squibb Co |
Pyrrolotriazine inhibitors of kinases
|
KR100718830B1
(ko)
|
1999-06-23 |
2007-05-17 |
사노피-아벤티스 도이칠란트 게엠베하 |
치환된 벤즈이미다졸 및 이의 제조방법
|
PE20010306A1
(es)
|
1999-07-02 |
2001-03-29 |
Agouron Pharma |
Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
|
TWI262914B
(en)
|
1999-07-02 |
2006-10-01 |
Agouron Pharma |
Compounds and pharmaceutical compositions for inhibiting protein kinases
|
US6844367B1
(en)
|
1999-09-17 |
2005-01-18 |
Millennium Pharmaceuticals, Inc. |
Benzamides and related inhibitors of factor Xa
|
US6967023B1
(en)
|
2000-01-10 |
2005-11-22 |
Foamix, Ltd. |
Pharmaceutical and cosmetic carrier or composition for topical application
|
YU54202A
(sh)
|
2000-01-18 |
2006-01-16 |
Agouron Pharmaceuticals Inc. |
Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
|
US20050009876A1
(en)
|
2000-07-31 |
2005-01-13 |
Bhagwat Shripad S. |
Indazole compounds, compositions thereof and methods of treatment therewith
|
US6897231B2
(en)
|
2000-07-31 |
2005-05-24 |
Signal Pharmaceuticals, Inc. |
Indazole derivatives as JNK inhibitors and compositions and methods related thereto
|
AU2001292670A1
(en)
|
2000-09-15 |
2002-03-26 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
AU2002222293A1
(en)
|
2000-12-19 |
2002-07-01 |
Smithkline Beecham P.L.C. |
Pyrazolo(3,4-c)pyridines as gsk-3 inhibitors
|
US20050192262A1
(en)
|
2001-03-13 |
2005-09-01 |
Tomas Hagstrom |
Treatment of tumours
|
WO2002088078A2
(en)
|
2001-04-30 |
2002-11-07 |
Vertex Pharmaceuticals Incorporated |
INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3β PROTEIN AND PROTEIN COMPLEXES
|
GB0115109D0
(en)
|
2001-06-21 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
WO2003004488A1
(en)
|
2001-07-03 |
2003-01-16 |
Chiron Corporation |
Indazole benzimidazole compounds as tyrosine and serine/threonine kinase inhibitors
|
US7642278B2
(en)
|
2001-07-03 |
2010-01-05 |
Novartis Vaccines And Diagnostics, Inc. |
Indazole benzimidazole compounds
|
WO2003024969A1
(en)
|
2001-09-14 |
2003-03-27 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
AU2002368274A1
(en)
|
2001-09-13 |
2004-06-03 |
Genesoft, Inc. |
Methods of treating infection by drug resistant bacteria
|
US6648873B2
(en)
|
2001-09-21 |
2003-11-18 |
Durect Corp. |
Aural catheter system including anchor balloon and balloon inflation device
|
AU2002334217B2
(en)
|
2001-10-26 |
2008-07-03 |
Aventis Pharmaceuticals Inc. |
Benzimidazoles and analogues and their use as protein kinases inhibitors
|
US6897208B2
(en)
|
2001-10-26 |
2005-05-24 |
Aventis Pharmaceuticals Inc. |
Benzimidazoles
|
US7666867B2
(en)
|
2001-10-26 |
2010-02-23 |
University Of Connecticut |
Heteroindanes: a new class of potent cannabimimetic ligands
|
FR2831536A1
(fr)
|
2001-10-26 |
2003-05-02 |
Aventis Pharma Sa |
Nouveaux derives de benzimidazoles, leur procede de preparation, leur application a titre de medicament, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de kdr
|
US20030187026A1
(en)
|
2001-12-13 |
2003-10-02 |
Qun Li |
Kinase inhibitors
|
AU2003225580A1
(en)
|
2002-02-19 |
2003-09-09 |
Pharmacia Corporation |
Tricyclic pyrazole derivatives for the treatment of inflammation
|
MXPA04008680A
(es)
|
2002-02-19 |
2004-12-06 |
Pharmacia Italia Spa |
Derivados de pirazol triciclicos, procedimientos para su preparacion y su uso como agentes anti-tumorales.
|
ES2411655T3
(es)
|
2002-05-17 |
2013-07-08 |
Pfizer Italia S.R.L. |
Derivados de aminoindazol activos como inhibidores de quinasas, procedimiento para su preparación y composiciones farmacéuticas que los comprenden
|
AU2003241925A1
(en)
|
2002-05-31 |
2003-12-19 |
Eisai R&D Management Co., Ltd. |
Pyrazole compound and medicinal composition containing the same
|
ES2304511T3
(es)
|
2002-06-04 |
2008-10-16 |
Schering Corporation |
Compuestos de pirazolo(1,5-a)pirimidina como agentes antivirales.
|
US7449488B2
(en)
|
2002-06-04 |
2008-11-11 |
Schering Corporation |
Pyrazolopyrimidines as protein kinase inhibitors
|
US20050282733A1
(en)
|
2002-06-27 |
2005-12-22 |
Prins Johannes B |
Differentiation modulating agents and uses therefor
|
GB0218625D0
(en)
|
2002-08-10 |
2002-09-18 |
Astex Technology Ltd |
Pharmaceutical compounds
|
FR2845382A1
(fr)
|
2002-10-02 |
2004-04-09 |
Sanofi Synthelabo |
Derives d'indazolecarboxamides, leur preparation et leur utilisation en therapeutique
|
DE602004029145D1
(de)
|
2003-02-27 |
2010-10-28 |
Palau Pharma Sa |
Pyrazolopyridin-derivate
|
US7135575B2
(en)
|
2003-03-03 |
2006-11-14 |
Array Biopharma, Inc. |
P38 inhibitors and methods of use thereof
|
ATE386034T1
(de)
|
2003-07-03 |
2008-03-15 |
Aventis Pharma Inc |
Pyrazoloisoquinolinenderivaten als kinase inhibitoren
|
TWI372050B
(en)
|
2003-07-03 |
2012-09-11 |
Astex Therapeutics Ltd |
(morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
|
PL1651612T3
(pl)
|
2003-07-22 |
2012-09-28 |
Astex Therapeutics Ltd |
Związki 3,4-pochodne 1h-pirazolu i ich zastosowanie jako kinazy zależne od cyklin (cdk) i modulatory kinazy syntazy glikogenu-3 (gsk-3)
|
CN1829713A
(zh)
|
2003-07-30 |
2006-09-06 |
辉瑞大药厂 |
3,5二取代的吲唑化合物、药物组合物和介导或抑制细胞增殖的方法
|
US7008953B2
(en)
|
2003-07-30 |
2006-03-07 |
Agouron Pharmaceuticals, Inc. |
3, 5 Disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
|
US20050090529A1
(en)
|
2003-07-31 |
2005-04-28 |
Pfizer Inc |
3,5 Disubstituted indazole compounds with nitrogen-bearing 5-membered heterocycles, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation
|
WO2005014554A1
(en)
|
2003-08-08 |
2005-02-17 |
Astex Therapeutics Limited |
1h-indazole-3-carboxamide compounds as mapkap kinase modulators
|
AU2004289539C1
(en)
|
2003-11-14 |
2012-06-07 |
Lorus Therapeutics Inc. |
Aryl imidazoles and their use as anti-cancer agents
|
EP1532980A1
(en)
|
2003-11-24 |
2005-05-25 |
Novo Nordisk A/S |
N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
|
FR2864084B1
(fr)
|
2003-12-17 |
2006-02-10 |
Aventis Pharma Sa |
Nouveaux derives organophosphores des indazoles et leur utilisation comme medicaments
|
FR2867778B1
(fr)
|
2004-03-16 |
2006-06-09 |
Sanofi Synthelabo |
Utilisation de derives d'indazolecarboxamides pour la preparation d'un medicament destine au traitement et a la prevention du paludisme
|
JP4995075B2
(ja)
|
2004-03-25 |
2012-08-08 |
メモリー・ファーマシューティカルズ・コーポレイション |
インダゾール、ベンゾチアゾール、ベンゾイソチアゾール、ベンズイソキサゾール、ならびにそれらの調製および使用
|
US7488737B2
(en)
|
2004-04-22 |
2009-02-10 |
Memory Pharmaceutical Corporation |
Indoles, 1H-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof
|
WO2005110410A2
(en)
|
2004-05-14 |
2005-11-24 |
Abbott Laboratories |
Kinase inhibitors as therapeutic agents
|
WO2006003440A1
(en)
|
2004-07-05 |
2006-01-12 |
Astex Therapeutics Limited |
3,4-disubstituted pyrazoles as cyclin dependent kinases (cdk) or aurora kinase or glycogen synthase 3 (gsk-3) inhibitors
|
US7626021B2
(en)
|
2004-07-27 |
2009-12-01 |
Sgx Pharmaceuticals, Inc. |
Fused ring heterocycle kinase modulators
|
CA2573573A1
(en)
|
2004-07-27 |
2006-02-09 |
Sgx Pharmaceuticals, Inc. |
Fused ring heterocycle kinase modulators
|
AR050188A1
(es)
|
2004-08-03 |
2006-10-04 |
Uriach Y Compania S A J |
Compuestos heterociclicos condensados utiles en terapia como inhibidores de quinasas p38 y composiciones farmaceuticas que los contienen
|
WO2006024945A1
(en)
|
2004-09-03 |
2006-03-09 |
Pfizer Inc. |
Pharmaceutical compositions comprising a cdk inhibitor
|
US7652043B2
(en)
|
2004-09-29 |
2010-01-26 |
The Johns Hopkins University |
WNT pathway antagonists
|
WO2006054143A1
(en)
|
2004-11-17 |
2006-05-26 |
Pfizer Inc. |
Polymorphs of {5-[3-(4,6-difluoro-1h-benzoimidazol-2-yl)-1h-indazol-5-yl]-4-methyl-pyridin-3-ylmethyl}-ethyl-amine
|
US20060116519A1
(en)
|
2004-11-17 |
2006-06-01 |
Agouron Pharmaceuticals, Inc. |
Synthesis of 5-bromo-4-methyl-pyridin-3-ylmethyl)-ethyl-carbamic acid tert-butyl ester
|
WO2006063302A2
(en)
|
2004-12-10 |
2006-06-15 |
Wyeth |
Variants of glycogen synthase kinase 3 and uses thereof
|
US20060142247A1
(en)
|
2004-12-17 |
2006-06-29 |
Guy Georges |
Tricyclic heterocycles
|
RU2416610C2
(ru)
|
2004-12-30 |
2011-04-20 |
Астекс Терапьютикс Лимитед |
Фармацевтические соединения
|
EP1861161A4
(en)
|
2005-01-24 |
2012-05-16 |
Neurosystec Corp |
APPARATUS AND METHOD FOR DISPENSING THERAPEUTIC AND / OR OTHER AGENTS IN THE INTERNAL EAR AND OTHER FABRICS
|
WO2006130673A1
(en)
|
2005-05-31 |
2006-12-07 |
Janssen Pharmaceutica, N.V. |
3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders
|
AU2006283941A1
(en)
|
2005-08-25 |
2007-03-01 |
F. Hoffmann-La Roche Ag |
P38 MAP kinase inhibitors and methods for using the same
|
US8106066B2
(en)
|
2005-09-23 |
2012-01-31 |
Memory Pharmaceuticals Corporation |
Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
|
AR055669A1
(es)
|
2005-10-03 |
2007-08-29 |
Astrazeneca Ab |
Derivados de 3h - imidazo[4, 5 -b]piridina como inhibidores selectivos de gsk3, metodos e internediarios para su preparacion, composiciones farmaceuticas que los contienen y su uso para la elaboracion de un medicamento para el tratamiento de enfermedades neurodegenerativas y mentales.
|
TW200804338A
(en)
|
2005-11-24 |
2008-01-16 |
Astrazeneca Ab |
New compounds
|
US8399442B2
(en)
|
2005-12-30 |
2013-03-19 |
Astex Therapeutics Limited |
Pharmaceutical compounds
|
GB0602178D0
(en)
|
2006-02-03 |
2006-03-15 |
Merck Sharp & Dohme |
Therapeutic treatment
|
US20090291968A1
(en)
|
2006-03-23 |
2009-11-26 |
Guy Georges |
Substituted indazole derivatives, their manufacture and use as pharmaceutical agents
|
MX2008012482A
(es)
|
2006-03-31 |
2008-10-10 |
Abbott Lab |
Compuestos de indazol.
|
ATE456565T1
(de)
|
2006-06-22 |
2010-02-15 |
Biovitrum Ab Publ |
Pyridin- und pyrazinderivate als mnk- kinaseinhibitoren
|
US20090263398A1
(en)
|
2006-07-14 |
2009-10-22 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
US7638518B2
(en)
|
2006-10-17 |
2009-12-29 |
Janssen Pharmaceutica |
Substituted pyrazole kinase inhibitors
|
WO2008061109A2
(en)
|
2006-11-15 |
2008-05-22 |
Forest Laboratories Holdings Limited |
Indazole derivatives useful as melanin concentrating receptor ligands
|
EP1932830A1
(en)
|
2006-12-11 |
2008-06-18 |
The Genetics Company, Inc. |
Sulfonamides and their use as a medicament
|
DE602006021591D1
(de)
|
2006-12-11 |
2011-06-09 |
Genetics Co Inc |
Aromatische 1,4-DI-Carboxylamide und deren Verwendung
|
JP2010513231A
(ja)
|
2006-12-14 |
2010-04-30 |
バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト |
たんぱく質キナーゼインヒビターとして有用なジヒドロピリジン誘導体
|
BRPI0809500A2
(pt)
|
2007-04-10 |
2014-09-23 |
Sgx Pharmaceuticals Inc |
Composto, e, métodos para modular a atividade de uma proteína quinase e para tratar uma doença
|
WO2008137408A1
(en)
|
2007-04-30 |
2008-11-13 |
Genentech, Inc. |
Pyrazole inhibitors of wnt signaling
|
ES2584188T3
(es)
|
2007-05-10 |
2016-09-26 |
Avalon Pharmaceuticals |
Derivados de fluoreno, antraceno, xanteno, dibenzosuberona y acridina y usos de los mismos
|
US20080287452A1
(en)
|
2007-05-16 |
2008-11-20 |
Wyeth |
Heteroaryl/aryl pyrimidine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system
|
US8304408B2
(en)
|
2007-05-24 |
2012-11-06 |
The Regents Of The University Of California |
Wnt signaling inhibitors, and methods for making and using them
|
CL2008001540A1
(es)
|
2007-05-29 |
2009-05-22 |
Sgx Pharmaceuticals Inc |
Compuestos derivados de pirrolopiridinas y pirazolopiridinas; composicion farmaceutica; y uso en el tratamiento del cancer.
|
WO2008150845A1
(en)
|
2007-05-31 |
2008-12-11 |
Vanderbilt University |
Screening for wnt pathway modulators and pyrvinium for the treatment of cance
|
KR20100032886A
(ko)
|
2007-06-08 |
2010-03-26 |
아보트 러보러터리즈 |
키나제 억제제로서의 5-헤테로아릴 치환된 인다졸
|
US8648069B2
(en)
|
2007-06-08 |
2014-02-11 |
Abbvie Inc. |
5-substituted indazoles as kinase inhibitors
|
US20110301155A1
(en)
|
2007-06-19 |
2011-12-08 |
Tsuneo Yasuma |
Indazole compounds for activating glucokinase
|
FR2917735B1
(fr)
|
2007-06-21 |
2009-09-04 |
Sanofi Aventis Sa |
Nouveaux indazoles substitutes, leur preparation et leur utilisation en therapeutique
|
US20090069288A1
(en)
|
2007-07-16 |
2009-03-12 |
Breinlinger Eric C |
Novel therapeutic compounds
|
US20100190736A1
(en)
|
2007-08-02 |
2010-07-29 |
Nerviano Medical Sciences S.R.L. |
Morpholinyl anthracycline derivative combined with protein kinase inhibitors
|
RU2350271C1
(ru)
|
2007-08-20 |
2009-03-27 |
Федеральное государственное учреждение "Российский научный центр "Восстановительная травматология и ортопедия" имени академика Г.А. Илизарова Федерального агентства по высокотехнологичной медицинской помощи", ФГУ "РНЦ "ВТО" им. акад. Г.А. Илизарова Росмедтехнологий" |
Способ лечения ранних стадий остеоартроза тазобедренного сустава
|
WO2009029609A1
(en)
|
2007-08-27 |
2009-03-05 |
Wyeth |
Imidazopyridine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system
|
US9259399B2
(en)
|
2007-11-07 |
2016-02-16 |
Cornell University |
Targeting CDK4 and CDK6 in cancer therapy
|
AU2008343062B2
(en)
*
|
2007-12-19 |
2013-03-07 |
Genentech, Inc. |
8-Anilinoimidazopyridines and their use as anti-cancer and/or anti-inflammatory agents
|
AU2009260503B2
(en)
|
2008-05-27 |
2014-03-27 |
The Board Of Regents Of The University Of Texas System |
Wnt protein signalling inhibitors
|
KR20110036583A
(ko)
|
2008-06-20 |
2011-04-07 |
로타팜 에스.피.에이. |
6-1h-이미다조-퀴나졸린 및 퀴놀린 유도체, 신규 mao 억제제 및 이미다졸린 수용체 리간드
|
KR101061599B1
(ko)
|
2008-12-05 |
2011-09-02 |
한국과학기술연구원 |
비정상 세포 성장 질환의 치료를 위한 단백질 키나아제 저해제인 신규 인다졸 유도체, 이의 약학적으로 허용가능한염 및 이를 유효성분으로 함유하는 약학적 조성물
|
CN101440092B
(zh)
|
2008-12-25 |
2010-11-17 |
浙江大学 |
2-吲唑-4-氮杂吲哚-5-氨基衍生物及制备和应用
|
AR075858A1
(es)
|
2009-03-18 |
2011-05-04 |
Schering Corp |
Compuestos biciclicos como inhibidores de diacilglicerol aciltransferasa
|
CA2755768A1
(en)
|
2009-03-23 |
2010-09-30 |
Merck Sharp & Dohme Corp. |
P2x3, receptor antagonists for treatment of pain
|
JP2012526850A
(ja)
|
2009-05-13 |
2012-11-01 |
ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル |
サイクリン依存性キナーゼ阻害剤及びその用法
|
UA110324C2
(en)
|
2009-07-02 |
2015-12-25 |
Genentech Inc |
Jak inhibitory compounds based on pyrazolo pyrimidine
|
SG177740A1
(en)
|
2009-07-23 |
2012-02-28 |
Univ Vanderbilt |
Substituted benzoimidazolesulfonamides and substituted indolesulfonamides as mglur4 potentiators
|
BR112012002807B1
(pt)
|
2009-08-07 |
2018-07-10 |
Adama Makhteshim Ltd. |
Derivados de 5-flúor-2-oxopirimidina-1(2h)- caboxilato, composição e processo para controle e prevenção de ataque fúngico em uma planta de ataque fúngico em uma planta
|
CA2770320A1
(en)
*
|
2009-08-10 |
2011-02-17 |
Epitherix, Llc |
Indazoles as wnt/b-catenin signaling pathway inhibitors and therapeutic uses thereof
|
DK2987487T3
(da)
|
2009-08-10 |
2020-12-07 |
Samumed Llc |
Indazolinhibitorer af wnt-signalvejen og terapeutiske anvendelser deraf
|
US8348645B2
(en)
|
2009-08-11 |
2013-01-08 |
Woodward, Inc. |
Balanced pressure, variable displacement, dual lobe, single ring, vane pump
|
WO2011050245A1
(en)
|
2009-10-23 |
2011-04-28 |
Yangbo Feng |
Bicyclic heteroaryls as kinase inhibitors
|
DK3001903T3
(en)
|
2009-12-21 |
2017-12-18 |
Samumed Llc |
1H-PYRAZOLO [3,4 -?] PYRIDINES AND THERAPEUTIC APPLICATIONS THEREOF
|
RU2562977C2
(ru)
|
2009-12-21 |
2015-09-10 |
Эррэй Биофарма Инк. |
СОЕДИНЕНИЯ ЗАМЕЩЕННОГО N-(1Н-ИНДАЗОЛ-4-ИЛ)ИМИДАЗОЛ[1,2-a]ПИРИДИН-3-КАРБОКСАМИДА КАК ИНГИБИТОРЫ cFMS
|
CA2795370C
(en)
|
2010-04-06 |
2018-03-27 |
Peter Maccallum Cancer Institute |
Radioprotector compounds and methods
|
DE102010043379A1
(de)
|
2010-11-04 |
2012-05-10 |
Bayer Schering Pharma Aktiengesellschaft |
Substituierte 6-Fluor-1H-Pyrazolo[4,3-b]pyridine und ihre Verwendung
|
US20130310379A1
(en)
|
2010-11-19 |
2013-11-21 |
Constellation Pharmaceuticals |
Modulators of methyl modifying enzymes, compositions and uses thereof
|
CA2824220C
(en)
|
2011-01-13 |
2020-09-01 |
Novartis Ag |
Novel heterocyclic derivatives and their use in the treatment of neurological disorders
|
US8889684B2
(en)
|
2011-02-02 |
2014-11-18 |
Boehringer Ingelheim International Gmbh |
Azaindolylphenyl sulfonamides as serine/threonine kinase inhibitors
|
US9464065B2
(en)
|
2011-03-24 |
2016-10-11 |
The Scripps Research Institute |
Compounds and methods for inducing chondrogenesis
|
JP2014509660A
(ja)
|
2011-04-01 |
2014-04-21 |
ユニバーシティ・オブ・ユタ・リサーチ・ファウンデイション |
PDK1キナーゼの阻害剤としての置換3−(1H−ベンゾ{d}イミダゾール−2−イル)−1H−インダゾール類似体
|
WO2013019901A2
(en)
|
2011-08-02 |
2013-02-07 |
Buck Institute For Research On Aging |
Tropinol esters and related compounds to promote normal processing of app
|
CN103889976A
(zh)
|
2011-08-12 |
2014-06-25 |
弗·哈夫曼-拉罗切有限公司 |
吲唑化合物、组合物及使用方法
|
EP2742046A1
(en)
|
2011-08-12 |
2014-06-18 |
F.Hoffmann-La Roche Ag |
PYRAZOLO[3,4-c]PYRIDINE COMPOUNDS AND METHODS OF USE
|
MX359032B
(es)
|
2011-09-01 |
2018-09-12 |
Hoffmann La Roche |
Inhibidores de pirrolopirazina cinasa.
|
AU2012308570B2
(en)
|
2011-09-14 |
2016-11-10 |
Samumed, Llc |
Indazole-3-carboxamides and their use as Wnt/b-catenin signaling pathway inhibitors
|
PL2810198T3
(pl)
|
2012-01-30 |
2024-01-22 |
Universiteit Gent |
Związki przeciwinwazyjne
|
US20150087687A1
(en)
|
2012-03-23 |
2015-03-26 |
Dennis Brown |
Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo
|
PH12017500997A1
(en)
|
2012-04-04 |
2018-02-19 |
Samumed Llc |
Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
|
US9056874B2
(en)
|
2012-05-04 |
2015-06-16 |
Novartis Ag |
Complement pathway modulators and uses thereof
|
EA201401213A1
(ru)
|
2012-05-04 |
2015-04-30 |
Басф Се |
Замещенные пиразолсодержащие соединения и их применение в качестве пестицидов
|
DK2770994T3
(da)
|
2012-05-04 |
2019-11-11 |
Samumed Llc |
1h-pyrazolo[3,4-b]pyridiner og terapeutiske anvendelser deraf
|
CN105120862A
(zh)
*
|
2013-01-08 |
2015-12-02 |
萨穆梅德有限公司 |
Wnt信号途径的3-(苯并咪唑-2-基)-吲唑抑制剂及其治疗应用
|
US9346812B2
(en)
|
2013-01-16 |
2016-05-24 |
Signal Pharmaceuticals, Llc |
Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
|
US9327886B2
(en)
|
2013-03-13 |
2016-05-03 |
Bayer Healthcare Llc |
Vial container with collar cap
|
HUE035966T2
(en)
*
|
2013-03-14 |
2018-05-28 |
Galapagos Nv |
Compounds and compositions for the treatment of inflammatory diseases
|
FR3011239A1
(fr)
|
2013-10-01 |
2015-04-03 |
Univ Claude Bernard Lyon |
Nouveaux derives comprenant un groupe pyrazole et un groupe indole, utiles en tant qu'inhibiteurs de la kinase gsk3
|
BR112016021626A2
(pt)
|
2014-03-20 |
2018-05-15 |
Samumed, Llc |
indazol-3-carboxamidas 5-substituídas e preparação e uso das mesmas
|
WO2016040180A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
WO2016040193A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
|
WO2016040182A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
2-(1h-indazol-3-yl)-1h-imidazo[4,5-c]pyridine and therapeutic uses thereof
|
US9538272B2
(en)
|
2014-09-08 |
2017-01-03 |
Apple Inc. |
Acoustic mesh and methods of use for electronic devices
|
WO2016040185A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
2-(1h-indazol-3-yl)-3h-imidazo[4,5-b]pyridine and therapeutic uses thereof
|
WO2016040184A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
WO2016040188A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
WO2016040190A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
|
WO2016040181A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
WO2017024021A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof
|
US20180228780A1
(en)
|
2015-08-03 |
2018-08-16 |
Samumed, Llc |
3-(1h-pyrrolo[2,3-c]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof
|
US10231956B2
(en)
|
2015-08-03 |
2019-03-19 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
WO2017024026A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-indol-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof
|
WO2017023972A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
WO2017023973A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-indol-2-yl)-1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
|
US10188634B2
(en)
|
2015-08-03 |
2019-01-29 |
Samumed, Llc |
3-(3H-imidazo[4,5-C]pyridin-2-yl)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
US10285983B2
(en)
|
2015-08-03 |
2019-05-14 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[3,4-B] pyridines and therapeutic uses thereof
|
WO2017023980A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof
|
US10383861B2
(en)
|
2015-08-03 |
2019-08-20 |
Sammumed, LLC |
3-(1H-pyrrolo[2,3-C]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
US10392383B2
(en)
|
2015-08-03 |
2019-08-27 |
Samumed, Llc |
3-(1H-benzo[d]imidazol-2-yl)-1H-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
US10226448B2
(en)
|
2015-08-03 |
2019-03-12 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-yl)-1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof
|
WO2017024015A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
US10226453B2
(en)
|
2015-08-03 |
2019-03-12 |
Samumed, Llc |
3-(1H-indol-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
US10463651B2
(en)
|
2015-08-03 |
2019-11-05 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1H-indazoles and therapeutic uses thereof
|
US10206908B2
(en)
|
2015-08-03 |
2019-02-19 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
WO2017024004A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
US10604512B2
(en)
|
2015-08-03 |
2020-03-31 |
Samumed, Llc |
3-(1H-indol-2-yl)-1H-indazoles and therapeutic uses thereof
|
WO2017023981A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
|
CA3004297A1
(en)
|
2015-11-06 |
2017-05-11 |
Samumed, Llc |
2-(1h-indazol-3-yl)-3h-imidazo[4,5-c]pyridines and their anti-inflammatory uses thereof
|
AR108325A1
(es)
|
2016-04-27 |
2018-08-08 |
Samumed Llc |
Isoquinolin-3-il carboxamidas y preparación y uso de las mismas
|
PL3464285T3
(pl)
|
2016-06-01 |
2023-02-06 |
Biosplice Therapeutics, Inc. |
Sposób wytwarzania n-(5-(3-(7-(3-fluorofenylo)-3h-imidazo[4,5-c]pirydyn-2-ylo)-1h-indazol-5-ilo)pirydyn-3-ylo)-3-metylobutanoamidu
|
JP2019535672A
(ja)
|
2016-10-21 |
2019-12-12 |
サミュメッド リミテッド ライアビリティ カンパニー |
インダゾール−3−カルボキサミドの使用方法およびwnt/β−カテニンシグナル伝達経路阻害剤としてのそれらの使用
|
MA46696A
(fr)
|
2016-11-07 |
2019-09-11 |
Samumed Llc |
Formulations injectables à dose unique prêtes à l'emploi
|
WO2020006115A1
(en)
|
2018-06-26 |
2020-01-02 |
Betty Tam |
Methods of treating cancer using a clk inhibitor
|
EP3911317A2
(en)
|
2019-01-17 |
2021-11-24 |
BioSplice Therapeutics, Inc. |
Methods of treating cartilage disorders through inhibition of clk and dyrk
|